Compare INDV & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | USAS |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2014 | 2004 |
| Metric | INDV | USAS |
|---|---|---|
| Price | $32.54 | $6.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.08 |
| AVG Volume (30 Days) | 2.2M | ★ 5.7M |
| Earning Date | 06-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 1.64 | N/A |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | N/A | $212.37 |
| Revenue Next Year | N/A | $42.64 |
| P/E Ratio | $20.09 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $8.69 | $0.50 |
| 52 Week High | $38.00 | $10.50 |
| Indicator | INDV | USAS |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 48.51 |
| Support Level | $31.70 | $4.71 |
| Resistance Level | $32.42 | $6.24 |
| Average True Range (ATR) | 1.18 | 0.43 |
| MACD | 0.39 | 0.14 |
| Stochastic Oscillator | 73.89 | 86.44 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.